“Receptor Tyrosine Kinase II”
A sequence of data can only be considered as a product produced directly by a patent-protected method when it displays technical features that it received by that method and it therefore by its nature can be suitable subject matter of a patent (following Federal Supreme Court decision of 21 August 2012, X ZR 33/10, BGHZ 194, 272 – MPEG-2-Videosignalcodierung).
The representation of a test result obtained by means of a patent-protected method and insights gained from it, as a presentation of information, does not represent a product that can enjoy protection under Sec. 9, second sentence, No. 3 of the Patent Act.